Back to search results

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Abroad (travel likely)RecruitingPHASE1

Conditions

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Elizabeth Budde, MD)
    Contact: Study coordinator (Qing Liu-Michael, PhD) · qliumichael@coh.org

  • Stanford University, Stanford, California, United States

    Contact: Study coordinator (Priya Sharma) · priyas33@stanford.edu · 650-723-1776
    Contact: Principal Investigator (Matthew Frank)

  • University of Kansas Hospital, Kansas City, Kansas, United States

    CTNurseNav · CTNurseNav@kumc.edu · 913-945-7552

  • University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Kayla Wagenmann, CRC-RN) · wage0074@umn.edu · 612-624-2342

  • Atrium Health Levine Cancer Institute - Morehead, Charlotte, North Carolina, United States

    Contact: Study coordinator (Alexandra M White) · Alexandra.M.White@advocatehealth.org · 800-821-1535

  • Providence Swedish Cancer Institute, Seattle, Washington, United States

    Contact: Study coordinator (Tori Braun) · tori.braun@swedish.org · 206-386-2525
Study leads

  • Elizabeth Budde, MD

    Study Chair

    City of Hope Medical Center

View source on ClinicalTrials.gov(opens in a new tab)